Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Pre-existing Antitherapeutic Antibodies Against the Fc Region of the Hu14.18K322A MAb Are Associated with Outcome in Patients with Relapsed Neuroblastoma. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: Pre-existing Antitherapeutic Antibodies Against the Fc Region of the Hu14.18K322A MAb Are Associated with Outcome in Patients with Relapsed Neuroblastoma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.